Once its diagnostic/prognostic value is verified in large‐scale samples and safe, effective interventions are developed, MCPIP1 is expected to evolve from a “basic research molecule” to a “practical tool” for the clinical diagnosis and treatment of PC. Here, ZC3H12A is linked to pachyonychia congenita.